Specialty Overview

Best Hospitals for Vaginal Cancer Treatment in Mumbai, India

17 medical oncology hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the medical oncology hospitals in our directory offering Vaginal Cancer Treatment in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Ask us about vaginal cancer treatment in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 17 accredited hospitals for Medical Oncology in Mumbai, India

Starting from$1,000

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering vaginal cancer treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Kokilaben Dhirubhai Ambani Hospital
Starting from$1,000

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 bedsHas a dedicated Medical Oncology department
Specialties & Accreditation
Medical OncologyCardiac SurgeryCardiologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering vaginal cancer treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's Medical Oncology department in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital
Starting from$1,000

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering vaginal cancer treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Apollo Hospitals, Navi Mumbai
Starting from$1,000

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by JCI, NABH

Patients considering vaginal cancer treatment can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Gleneagles Hospital, Mumbai
Starting from$1,000

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviewsAccredited by JCI, NABH638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering vaginal cancer treatment can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Lilavati Hospital And Research Centre
Starting from$1,000

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviewsAccredited by JCI, NABH326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering vaginal cancer treatment can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Jaslok Hospital
Starting from$1,000

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviewsAccredited by NABH, NABL350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Accredited by NABH, NABL

Patients considering vaginal cancer treatment can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Gleneagles Global Hospitals (Global Hospitals)
Starting from$1,000

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviewsAccredited by NABH, JCI450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Accredited by NABH, JCI

Patients considering vaginal cancer treatment can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Medicover Hospital, Navi Mumbai
Starting from$1,000

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviewsAccredited by NABH310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Accredited by NABH

Patients considering vaginal cancer treatment can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
KIMS Hospitals, Thane
Starting from$1,000

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by NABH

Patients considering vaginal cancer treatment can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing vaginal cancer treatment.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Vaginal Cancer Treatment in Mumbai, India?

Choosing the right hospital for vaginal cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include medical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Vaginal Cancer Treatment

Vaginal cancer is a rare but treatable gynecologic malignancy managed through a multidisciplinary combination of surgery, radiation therapy, and systemic chemotherapy, with five-year survival rates ranging from 84% for Stage I disease to approximately 57% overall across all stages when treated at high-volume oncology centers.

7–14 days (varies by stage and treatment modality; surgery alone typically 7–10 days, concurrent chemoradiation may require outpatient attendance over 5–7 weeks)
Hospital Stay
6–10 weeks (patients completing primary surgery are generally fit to fly in 4–6 weeks post-operatively; those completing concurrent chemoradiation require 2–4 weeks of recovery after the final fraction before long-haul travel is safe)
Total Stay in Country (Fit-to-Fly)
Stage I: ~84% five-year survival; Stage II: ~75%; All-stage combined: ~57% (SEER data, high-volume center outcomes)
Success Rate

Clinical Overview

  • Vaginal cancer accounts for approximately 1–2% of all gynecologic malignancies, with squamous cell carcinoma (SCC) comprising 85–90% of cases and adenocarcinoma, melanoma, and sarcoma constituting the remainder.
  • The vaginal epithelium is anatomically contiguous with the cervix superiorly and the vulva inferiorly, meaning malignant transformation — most frequently driven by persistent high-risk human papillomavirus (HPV) infection, particularly genotypes 16 and 18 — can produce lesions across a spectrum from vaginal intraepithelial neoplasia (VAIN) to invasive carcinoma.
  • Because the vagina lies in close proximity to the bladder, urethra, rectum, and pelvic sidewall vasculature, even localized disease carries significant implications for organ function, urinary and bowel continence, and sexual health.
Full details →

Who is a Candidate?

  • Confirmed histopathologic diagnosis of vaginal carcinoma (SCC, adenocarcinoma, or other histology) on colposcopy-directed biopsy or EUA biopsy
  • FIGO Stage I–IVA disease being considered for curative-intent treatment; Stage IVB patients evaluated for palliative or systemic protocols
  • ECOG Performance Status 0–2 (sufficient functional reserve for surgery or chemoradiation)
  • Adequate bone marrow reserve: ANC ≥1,500/µL, platelets ≥100,000/µL, hemoglobin ≥9 g/dL (for cisplatin eligibility)
  • +7 more

Treatment Options & Approaches

  • SURGICAL APPROACHES

Recovery

  • STEP 1 — PRE-ARRIVAL CONSULTATION (Weeks 1–2 before travel) Patients submit existing biopsy reports, imaging (MRI/PET-CT), operative notes, and pathology to GAF Healthcare's oncology coordination team.
  • A virtual multidisciplinary tumor board (gynecologic oncologist, radiation oncologist, medical oncologist, radiologist) reviews the case and provides a written treatment recommendation and itemized cost estimate within 48–72 hours.
  • Visa documentation (e-Medical Visa for India; UAE entry visa support) is initiated simultaneously.

Risks to be aware of

  • Vaginal cancer treatment carries meaningful procedural and treatment-related risks that patients must understand before committing to a care pathway.
  • Surgical risks include intraoperative hemorrhage (estimated blood loss >500 mL in up to 12% of radical vaginectomies), ureterovaginal or vesicovaginal fistula formation (2–5% in non-irradiated fields; higher post-radiation), wound dehiscence, pelvic lymphocele requiring drainage, deep vein thrombosis and pulmonary embolism (prophylaxed with LMWH and compression devices), and genitourinary dysfunction including urinary incontinence or retention requiring intermittent self-catheterization.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated non-medical support framework designed to eliminate logistical burden for international oncology patients and their families.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about Vaginal Cancer Treatment

What is the cost of Vaginal Cancer Treatment in India compared to the UAE?
The total cost of a complete vaginal cancer treatment course — encompassing staging workup (MRI pelvis, PET-CT, EUA biopsy, biomarker profiling), definitive treatment (surgery or concurrent chemoradiation with IMRT/VMAT and HDR brachytherapy), and post-treatment response assessment — ranges from approximately USD 5,000 to USD 18,000 at JCI- and NABH-accredited cancer centers in India, and from approximately USD 14,000 to USD 45,000 at JCI- and DHA-accredited oncology hospitals in Dubai and Abu Dhabi. India is typically 50–65% less expensive than the UAE for equivalent evidence-based protocols. The lower end of each range reflects early-stage (FIGO Stage I) surgical cases; the upper end reflects multi-modality treatment for Stage III–IVA disease incorporating extended chemoradiation, interstitial brachytherapy, and systemic immunotherapy. Both destinations include the primary surgical or radiation procedure, standard inpatient nursing and ward accommodation, routine medications and chemotherapy drugs, and immediate post-treatment imaging. International airfares, personal travel expenses, and costs of targeted therapies or immunotherapy agents (e.g., pembrolizumab, bevacizumab) may be itemized separately. GAF Healthcare provides a detailed, individualized cost estimate within 48–72 hours of receiving the patient's case records, with no hidden fees.
How long do I need to stay in India or the UAE before I am fit to fly home after Vaginal Cancer Treatment?
The minimum safe in-country stay before long-haul international travel depends on which treatment modality is used. For patients who undergo primary radical vaginectomy (surgery), the fit-to-fly window is typically 4–6 weeks after the operative date, provided that the surgical wound has healed completely, the urinary catheter has been removed and voiding function confirmed, post-operative histology has been reviewed, and no complications such as deep vein thrombosis (DVT), lymphocele, or fistula are present. Total in-country stay for surgical patients is therefore approximately 6–8 weeks (including the pre-operative staging workup of 5–7 days). For patients completing concurrent cisplatin-based chemoradiation with external beam radiotherapy (IMRT over 5–6 weeks) followed by high-dose-rate (HDR) brachytherapy boost (1–2 additional weeks), the total treatment duration in-country is 7–9 weeks. Fit-to-fly clearance after the final brachytherapy fraction requires an additional 2–4 weeks for acute radiation toxicities — primarily bowel and bladder inflammation — to stabilize to a manageable level (CTCAE Grade ≤1). Total in-country stay for chemoradiation patients is therefore approximately 9–12 weeks. All patients receive individualized fit-to-fly assessment by their treating team, and GAF Healthcare issues a formal medical clearance letter and thromboprophylaxis prescription (low-molecular-weight heparin for flights exceeding 6 hours) prior to departure.
What is the success rate for Vaginal Cancer Treatment?
Vaginal cancer outcomes are strongly stage-dependent and are most accurately described using five-year disease-specific survival rates from large-volume cancer registries and institutional data. For FIGO Stage I disease (confined to the vaginal wall, tumor ≤2 cm), five-year survival rates reach 84–90% at high-volume gynecologic oncology centers using radical surgery or definitive brachytherapy-based chemoradiation. Stage II disease (paravaginal extension without pelvic sidewall involvement) carries a five-year survival rate of approximately 75–78% with concurrent cisplatin-based chemoradiation and IMRT/brachytherapy. Stage III disease (pelvic sidewall involvement, lower-vaginal extension, or regional nodal metastasis) has a five-year survival rate of approximately 52–58%. Stage IVA (bladder or rectal invasion) rates are approximately 36–42%, while Stage IVB (distant metastasis) is managed palliatively with systemic therapy and achieves median overall survival of 12–18 months with modern platinum-doublet plus bevacizumab or pembrolizumab regimens in biomarker-selected patients. The adoption of MRI-guided adaptive brachytherapy (following GEC-ESTRO recommendations), IMRT dose optimization, and immunotherapy in PD-L1-positive tumors has improved outcomes compared to historical cohorts. GAF Healthcare partners exclusively with high-volume oncology centers where gynecologic oncology tumor boards review every case, ensuring that each patient receives the most current, guideline-compliant treatment to maximize their individual probability of disease control and cure.

How GAF Healthcare Assists in Choosing the Best Hospital for Vaginal Cancer Treatment in Mumbai, India

Discover the Top Hospitals for Vaginal Cancer Treatment in Mumbai, India

This page lists 17 accredited medical oncology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about vaginal cancer treatment in Mumbai, India

How many medical oncology hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for medical oncology including Vaginal Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there medical oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for vaginal cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about vaginal cancer treatment in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for vaginal cancer treatment in Mumbai, India.

Contact us to report an inaccuracy on this page.